|
MSL3L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.557850E-04 |
| Normal-vs-Stage3 |
2.759600E-04 |
| Normal-vs-Stage4 |
1.343000E-01 |
| Stage1-vs-Stage2 |
4.083600E-01 |
| Stage1-vs-Stage3 |
1.028640E-01 |
| Stage1-vs-Stage4 |
5.954800E-01 |
| Stage2-vs-Stage3 |
3.155800E-01 |
| Stage2-vs-Stage4 |
7.621600E-01 |
| Stage3-vs-Stage4 |
8.266400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.00169991693144E-10 |
| Normal-vs-Asian |
2.444400E-01 |
| Caucasian-vs-AfricanAmerican |
8.549200E-01 |
| Caucasian-vs-Asian |
6.182800E-01 |
| AfricanAmerican-vs-Asian |
6.039800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.46249998170356E-09 |
| Male-vs-Female |
7.127600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.45410000000646E-05 |
| Normal-vs-Extreme_Weight |
1.07802655691103E-13 |
| Normal-vs-Obese |
1.06630038132494E-10 |
| Normal-vs-Extreme_Obese |
4.161200E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.742600E-01 |
| Normal_Weight-vs-Obese |
7.687400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.086200E-01 |
| Extreme_Weight-vs-Obese |
1.353780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.823400E-01 |
| Obese-vs-Extreme_Obese |
9.150800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.580000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(61-80Yrs) |
2.99760216648792E-15 |
| Normal-vs-Age(81-100Yrs) |
1.163740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.173800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.783360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.425400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.670500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.721000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.609600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.83950000001809E-06 |
| Normal-VS-KIRP CIMP |
2.001000E-01 |
| Normal-VS-Unclassified PRCC |
1.67079999946473E-07 |
| Type1 PRCC-VS-Type2 PRCC |
8.178400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.407000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.207800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.292400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.852000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.407830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.42919999951619E-07 |
| Normal-vs-N1 |
1.064630E-03 |
| Normal-vs-N2 |
2.663000E-01 |
| N0-vs-N1 |
3.945600E-02 |
| N0-vs-N2 |
5.056400E-01 |
| N1-vs-N2 |
2.673700E-02 |
|
|
